PECULIARITIES OF THE CLINICAL COURSE OF HEREDITARY OVARIAN CANCER
Abstract
About the Authors
R. R. FaiskhanovaRussian Federation
D. D. Sakaeva
Russian Federation
E. K. Khusnutdinova
Russian Federation
References
1. Наследственный рак молочной железы и/или яичников: ДНК-диагностика, индивидуальный прогноз, лечение и профилактика / Л.Н. Любченко//дис. … д-ра мед. наук: 14.00.14 / Любченко Людмила Николаевна. - М., 2009. - 282 с
2. Наследственный рак яичников: вклад изменений генов-кандидатов в патогенез заболевания /Р.Р. Фаисханова, Д.С. Прокофьева, Э.К. ХуснутдиноваЭ,К [и др.]//Медицинская генетика. - 2019. - Т. 18, №. 11. - С. 3-13
3. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group/ К. Alsop, S. Fereday,C. Meldrum C. [et al.] // J. Clin. Oncol. - 2012. - Vol. 30, № 21. - P. 2654
4. BRCA mutation in high grade epithelial ovarian cancers / T. Manchana, N. Phoolcharoen, P. Tantbirojn // Gynecol. Oncol. Rep. - 2019. - Vol. 29. - P. 102-105
5. The pattern of gene expression in various histotypes of epithelial ovarian cancer correlates with those in the normal fallopian tube, endometrium, and colon /R.T.Marquez, K.A.Baggerly, A.P.Patterson [et al.] // Clin. Cancer Res. - 2005. - Vol. 11, № 17. - P. 6116-6126
6. Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas/A.Niskakoski, S.Kau, Renkonen-Sinisalo L.[et al.]/// Int. J. Cancer. - 2013. - Vol. 133, № 11. - P. 2596-2608
7. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families /D.Ford, D.F.Easton, M. Stratton [et al.]/// Am. J. Hum. Genet. - 1998. - Vol. 62. - P. 676-689
Review
For citations:
Faiskhanova R.R., Sakaeva D.D., Khusnutdinova E.K. PECULIARITIES OF THE CLINICAL COURSE OF HEREDITARY OVARIAN CANCER. Bashkortostan Medical Journal. 2021;16(3):46-50. (In Russ.)